SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001104659-19-057503
Filing Date
2019-10-30
Accepted
2019-10-30 07:30:47
Documents
14
Period of Report
2019-10-30
Items
Item 2.02: Results of Operations and Financial Condition
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm1921398-1_8k.htm   iXBRL 8-K 32199
2 EXHIBIT 99.1 tm1921398d1_ex99-1.htm EX-99.1 134552
3 GRAPHIC tm19213981_ex99-1image001.jpg GRAPHIC 2671
  Complete submission text file 0001104659-19-057503.txt   367673

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA insm-20191030.xsd EX-101.SCH 3180
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE insm-20191030_lab.xml EX-101.LAB 34591
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE insm-20191030_pre.xml EX-101.PRE 22706
10 EXTRACTED XBRL INSTANCE DOCUMENT tm1921398-1_8k_htm.xml XML 3609
Mailing Address 10 FINDERNE AVENUE BUILDING 10 BRIDGEWATER NJ 08807
Business Address 10 FINDERNE AVENUE BUILDING 10 BRIDGEWATER NJ 08807 908-977-9900
INSMED Inc (Filer) CIK: 0001104506 (see all company filings)

IRS No.: 541972729 | State of Incorp.: VA | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-30739 | Film No.: 191177788
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences